Wells Fargo
IMCR icon

Wells Fargo’s Immunocore IMCR Stock Holding History

Wells Fargo’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Sell
75,473
-1,755
-2% -$56.8K ﹤0.01% 3182
2025
Q4 		$2.68M Sell
77,228
-6,453
-8% -$228K ﹤0.01% 3206
2025
Q3 		$3.04M Buy
83,681
+2,920
+4% +$99.2K ﹤0.01% 3001
2025
Q2 		$2.53M Sell
80,761
-2,909
-3% -$90.4K ﹤0.01% 3030
2025
Q1 		$2.48M Buy
83,670
+11,735
+16% +$352K ﹤0.01% 2993
2024
Q4 		$2.12M Sell
71,935
-11,120
-13% -$352K ﹤0.01% 3147
2024
Q3 		$2.59M Buy
83,055
+1,273
+2% +$46.3K ﹤0.01% 2855
2024
Q2 		$2.77M Sell
81,782
-4,314
-5% -$220K ﹤0.01% 2723
2024
Q1 		$5.6M Buy
86,096
+1,953
+2% +$134K ﹤0.01% 2175
2023
Q4 		$5.75M Buy
84,143
+13,698
+19% +$712K ﹤0.01% 2113
2023
Q3 		$3.66M Buy
70,445
+17,215
+32% +$1.02M ﹤0.01% 2335
2023
Q2 		$3.19M Buy
53,230
+52,834
+13,342% +$3.02M ﹤0.01% 2518
2023
Q1 		$19.6K Sell
396
-431
-52% -$24.2K ﹤0.01% 5648
2022
Q4 		$47.2K Buy
827
+391
+90% +$22K ﹤0.01% 4891
2022
Q3 		$20K Buy
+436
New +$20.8K ﹤0.01% 5396

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Wells Fargo's IMCR Position: Q1 2026 in Review

Wells Fargo reduced its Immunocore (IMCR) stake by 2.3% in Q1 2026, selling an estimated $56.8K and leaving 75,473 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3182.

Wells Fargo first reported a position in IMCR in Q3 2022 and has held it in 15 quarters since. The position peaked at $5.75M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Wells Fargo held 75,473 shares of Immunocore worth $2.28M as of Q1 2026.
  • Wells Fargo sold 1,755 Immunocore shares in Q1 2026, an estimated $56.8K.
  • Immunocore made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3182 holding.
  • Wells Fargo first reported a position in Immunocore in Q3 2022 and has held it in 15 quarters since.
  • Wells Fargo's Immunocore position peaked at $5.75M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.